Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II
WHIPLASH
Efficacy and Safety of the Combination Dexketoprofen / Vitamin B Vs Dexketoprofen in the Treatment of Pain in Patients with Post-traumatic Cervical Sprain Grade I-II of the Quebec Scale.
1 other identifier
interventional
174
1 country
1
Brief Summary
Phase IIIb, multicenter, prospective, randomized, double-blind study to evaluate the fixed combination of Desketoprofen / Vitamin B in the management of acute pain in patients with cervical sprain grade I-II of the Quebec scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2021
CompletedFirst Posted
Study publicly available on registry
August 12, 2021
CompletedStudy Start
First participant enrolled
November 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2023
CompletedNovember 13, 2024
November 1, 2024
1.4 years
July 29, 2021
November 11, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Changes in pain intensity
Compare changes in pain intensity measured by the visual analog scale (VAS) between treatment groups. The VAS for pain is a straight line of 10 centimeters in which one end means no pain and the other end means the worst pain imaginable.
Baseline, 3, 5 and 7 days
Change in the degree of disability
Compare the degree of disability due to neck pain measured through the Northwick Park Neck Pain Questionnaire Spanish version between the treatment groups. It includes 9 questions or items (intensity of neck pain, and sleep, pins and needles in the arms at night, duration of symptoms, lifting weights, reading and watching TV, work, social activities and driving). Each of these questions has five possible answers with a score of 0 to 4, from less to greater intensity and severity respectively.
Baseline, 3, 5 and 7 days
Proportion of subjects requiring rescue medication
Compare the proportion of subjects requiring rescue medication during the study between treatment groups.
7 days
Adverse events frequency
Compare the proportion of subjects that presented an adverse event between treatment groups.
7 days
Adverse events intensity
Compare the intensity of adverse events presented during the study, between treatment groups.
7 days
Study Arms (2)
Group A: Dexketoprofen/Vitamin B (Thiamine mononitrate/Pyridoxine hydrochloride/Cyanocobalamin)
EXPERIMENTALGroup A: Dexketoprofen/Vitamin B (Thiamine mononitrate/Pyridoxine hydrochloride/Cyanocobalamin), 1 capsule, orally, every 8 hours, for 7 days.
Group B: Dexketoprofen
ACTIVE COMPARATORGroup B: Dexketoprofen, 1 tablet, orally, every 8 hours, for 7 days.
Interventions
1 capsule containing 25 mg of dexketoprofen / vitamin B (thiamine mononitrate 100 mg, Pyridoxine hydrochloride 50 mg, Cyanocobalamin 0.50 mg), orally, every 8 hours, for 7 days.
1 tablet of dexketoprofen 25 mg, orally, every 8 hours, for 7 days.
Eligibility Criteria
You may qualify if:
- Any sex.
- That the subject agree to participate in the study and give your written informed consent.
- Age\> 18 years old at the beginning of the study.
- Diagnosis of a grade I or Grade II cervical sprain on the Quebec scale of no more than 3 days.
- Visual Analog Scale (VAS) ≥4 cm.
- Women of childbearing potential using a contraceptive method (barrier, oral hormonal, injectable, subdermal), menopausal or surgically sterile.
You may not qualify if:
- Patient in whom the drug is contraindicated for medical reasons.
- History of allergic reaction to NSAIDs, thiamine, pyridoxine and cyanocobalamin or hypersensitivity to the components of the formula.
- A significant history of gastrointestinal disorders (for example: Gastric Ulcer, Crohn's Disease, Ulcerative Colitis, etc.)
- Previous treatment with opioids reported in the medical history.
- History of inflammatory arthritis (eg rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, gout).
- History of chronic pain (eg, fibromyalgia), metastasis, and Paget's disease.
- History of alcohol or drug abuse in the last year according to DSM-V.
- Clinical and radiological data of cervical sprain grade III or IV of the Quebec scale.
- History of illness or injury for more than 6 months in the neck or cervical spine
- Patient with symptoms of spinal cord injury (weakness, incoordination or paralysis in any part of the body, numbness, tingling or loss of sensation in the hands, fingers, feet or toes, etc.)
- History of severe acute or chronic liver failure.
- History of moderate to severe renal failure.
- A significant history of coagulation problems (Von Willembrand, hemophilia, vitamin K deficiency, etc.).
- At medical discretion, a disease that affects the prognosis and prevents outpatient management, for example, but not restricted to: end-stage cancer, kidney, heart, respiratory or liver failure or mental illness or with scheduled surgical or hospital procedures.
- History / presence of any disease or condition that, in the opinion of the Investigator, could pose a risk to the patient or confuse the efficacy and safety of the study results.
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratorio Silanes, S.A. de C.V.
Mexico City, Mexico City, 11000, Mexico
Related Publications (13)
Spitzer WO, Skovron ML, Salmi LR, Cassidy JD, Duranceau J, Suissa S, Zeiss E. Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine (Phila Pa 1976). 1995 Apr 15;20(8 Suppl):1S-73S. No abstract available.
PMID: 7604354BACKGROUNDRodriquez AA, Barr KP, Burns SP. Whiplash: pathophysiology, diagnosis, treatment, and prognosis. Muscle Nerve. 2004 Jun;29(6):768-81. doi: 10.1002/mus.20060.
PMID: 15170609BACKGROUNDHartling L, Brison RJ, Ardern C, Pickett W. Prognostic value of the Quebec Classification of Whiplash-Associated Disorders. Spine (Phila Pa 1976). 2001 Jan 1;26(1):36-41. doi: 10.1097/00007632-200101010-00008.
PMID: 11148643BACKGROUNDBagan JV, Lopez Arranz JS, Valencia E, Santamaria J, Eguidazu I, Horas M, Forns M, Zapata A, Artigas R, Mauleon D. Clinical Comparison of Dexketoprofen Trometamol and Dipyrone in Postoperative Dental Pain. J Clin Pharmacol. 1998 Dec;38(S1):55S-64S. doi: 10.1002/jcph.1998.38.s1.55.
PMID: 29023870BACKGROUNDPonce-Monter HA, Ortiz MI, Garza-Hernandez AF, Monroy-Maya R, Soto-Rios M, Carrillo-Alarcon L, Reyes-Garcia G, Fernandez-Martinez E. Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Res Treat. 2012;2012:104782. doi: 10.1155/2012/104782. Epub 2011 Oct 31.
PMID: 22135737BACKGROUNDCuratolo M, Sveticic G. Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Pract Res Clin Anaesthesiol. 2002 Dec;16(4):507-19. doi: 10.1053/bean.2002.0254.
PMID: 12516888BACKGROUNDLevin OS, Moseikin IA. [Vitamin B complex (milgamma) in the treatment of vertebrogenic lumbosacral radiculopathy]. Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(10):30-5. Russian.
PMID: 20037567BACKGROUNDKuhlwein A, Meyer HJ, Koehler CO. [Reduced diclofenac administration by B vitamins: results of a randomized double-blind study with reduced daily doses of diclofenac (75 mg diclofenac versus 75 mg diclofenac plus B vitamins) in acute lumbar vertebral syndromes]. Klin Wochenschr. 1990 Jan 19;68(2):107-15. doi: 10.1007/BF01646857. German.
PMID: 2138683BACKGROUNDPerez-Flores E, Medina-Santillan R, Reyes-Garcia G, Mateos-Garcia E. Combination of diclofenac plus B vitamins in acute pain after tonsillectomy: a pilot study. Proc West Pharmacol Soc. 2003;46:88-90. No abstract available.
PMID: 14699896BACKGROUNDMibielli MA, Geller M, Cohen JC, Goldberg SG, Cohen MT, Nunes CP, Oliveira LB, da Fonseca AS. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009 Nov;25(11):2589-99. doi: 10.3111/13696990903246911.
PMID: 19731994BACKGROUNDGonzalez T, Balsa A, Sainz de Murieta J, Zamorano E, Gonzalez I, Martin-Mola E. Spanish version of the Northwick Park Neck Pain Questionnaire: reliability and validity. Clin Exp Rheumatol. 2001 Jan-Feb;19(1):41-6.
PMID: 11247324BACKGROUNDGaskell H, Derry S, Wiffen PJ, Moore RA. Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2017 May 25;5(5):CD007355. doi: 10.1002/14651858.CD007355.pub3.
PMID: 28540716BACKGROUNDDelgado-Garcia P, Alcocer-Herrera JB, Urenda-Quezada A, Alonso-Martinez MD, Bautista-Mendoza MA, Romero-Antonio Y, Mora-Villalobos JC, Sander-Padilla JG, Rios-Brito KF, Rodriguez-Vazquez IC, Gonzalez-Canudas J. A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains. Clin Drug Investig. 2024 Jun;44(6):413-424. doi: 10.1007/s40261-024-01370-2. Epub 2024 Jun 6.
PMID: 38842764DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pamela Delgado García, M.D
IMACEN S.A. de C.V.,
- PRINCIPAL INVESTIGATOR
Adelfia Urenda Quezada, M.D
Mediadvance Clinical S.A.P.I. de C.V.
- PRINCIPAL INVESTIGATOR
Ma. Dolores Alonso Martínez, M.D
CICMEX Centro de Investigación Clínica de México
- PRINCIPAL INVESTIGATOR
Juan B Alcocer Herrera, M.D
INBIOMEDyC Querétaro
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2021
First Posted
August 12, 2021
Study Start
November 23, 2021
Primary Completion
April 24, 2023
Study Completion
April 25, 2023
Last Updated
November 13, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share